Efficacy of deferasirox in reducing and preventing cardiac iron overload...
Cardiac iron overload causes most deaths in β-thalassemia major. The efficacy of deferasirox in reducing...
ادامه مطلبCardiac iron overload causes most deaths in β-thalassemia major. The efficacy of deferasirox in reducing...
ادامه مطلبDeferasirox is an orally administered, once-daily iron chelator with a generally good safety and efficacy...
ادامه مطلبIron overload is frequently leads to excessive iron deposition observed in patients with thalassemia...
ادامه مطلبPatients with thalassemia have low circulating levels of many nutrients, but the contribution of dietary...
ادامه مطلبPurpose of the study: to determine the efficacy, adverse effects and safety of a new Iranian generic...
ادامه مطلبIron overload is the primary cause ofmortality andmorbidity in thalassemiamajor despite advances in chelation...
ادامه مطلب